LCM
TCRT icon

Laurion Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Laurion Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,137
Closed -$2.92M – 671
2023
Q2 		$2.92M Hold
38,137
– – 0.02% 291
2023
Q1 		$3.6M Hold
38,137
– – 0.02% 251
2022
Q4 		$3.71M Buy
38,137
+10,000
+36% +$1.45M 0.02% 280
2022
Q3 		$7.26M Sell
28,137
-458
-2% -$133K 0.04% 220
2022
Q2 		$5.32M Buy
+28,595
New +$2.73M 0.08% 157
2015
Q4 		– Sell
-119
Closed -$160K – 1042
2015
Q3 		$160K Sell
119
-106
-47% -$175K ﹤0.01% 694
2015
Q2 		$406K Buy
+225
New +$349K ﹤0.01% 491

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Laurion Capital Management's TCRT Position: Q3 2023 in Review

Laurion Capital Management sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 38,137 shares — an estimated $2.92M sold.

Laurion Capital Management first reported a position in TCRT in Q2 2015 and held it in 7 quarters. The position peaked at $7.26M in Q3 2022. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.

  • Laurion Capital Management reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Laurion Capital Management sold 38,137 Alaunos Therapeutics shares in Q3 2023, an estimated $2.92M.
  • Laurion Capital Management first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 7 quarters.
  • Laurion Capital Management's Alaunos Therapeutics position peaked at $7.26M in Q3 2022.
  • 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.